↓ Skip to main content

Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID…

Overview of attention for article published in Trials, February 2022
Altmetric Badge

Mentioned by

twitter
3 X users

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
Published in
Trials, February 2022
DOI 10.1186/s13063-022-06073-7
Pubmed ID
Authors

Francisco Mera-Cordero, Sara Bonet-Monne, Jesús Almeda-Ortega, Ana García-Sangenís, Oriol Cunillera-Puèrtolas, Sara Contreras-Martos, Gemma Alvarez-Muñoz, Ramon Monfà, Marina Balanzó-Joué, Rosa Morros, Betlem Salvador-Gonzalez

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Other 11 29%
Unspecified 3 8%
Student > Ph. D. Student 3 8%
Researcher 3 8%
Student > Bachelor 1 3%
Other 6 16%
Unknown 11 29%
Readers by discipline Count As %
Unspecified 11 29%
Nursing and Health Professions 4 11%
Medicine and Dentistry 4 11%
Social Sciences 3 8%
Sports and Recreations 1 3%
Other 3 8%
Unknown 12 32%